HealthQuill chronic obstructive pulmonary disease (COPD)
Israelā€™s Teva Pharmaceutical Industries, and US-basedĀ Launch Therapeutics, have joined hands to speed up the development of an experimental asthma drug.
Drugs Health

New treatment for severe asthma attacks in 50 years

Bharti Jayshankar November 29, 2024: Around half a billion people live with asthma and chronic obstructive pulmonary disease (COPD). The Global Burden of.

Read More
Merckā€™s Biological Licence Application for a pulmonary arterial hypertension drug has been accepted for a priority review by the FDA.
Drugs Health Pharma

GSK’s Nucala Phase III trial shows promise in treating chronic lung disease

September 6, 2024: UK pharmaceutical giant GSK (GSK.L) announced that its asthma medicine, Nucala (mepolizumab), has shown positive results in a late-stage clinical.

Read More